Redcliffe Labs

Redcliffe Labs Unveils Mpox Testing Amid Rising Concerns September 3, 2024 This move is part of the company’s strategy to bolster preparedness against potential public health threats posed by the virus.

Indian Diagnostics Sector Set for Rapid Growth: Report August 8, 2024 The broader Indian healthcare sector is experiencing a transformative phase, with a market size of US$ 216 billion as of FY23.

Redcliffe Labs Introduces Prostate Health Index Test to Address Rising Prostate Cancer Cases in India November 2, 2023 Recognising the mounting concern related to prostate cancer in India, the PHI test serves as a valuable tool in determining the necessity for a prostate biopsy.

Noida-Based Redcliffe Labs Breaches 1.2 Cr Sensitive Medical Data, Company Denies October 30, 2023 The breach was discovered by cybersecurity researcher Jeremiah Fowler, who found an unprotected database housing extensive medical data.

Redcliffe Labs Sets Precise Metrics to Help Identify PCOS More Accurately September 20, 2023 The company conducted a study focusing on Indian women to define a diagnostic threshold for Polycystic Ovarian Syndrome (PCOS).

Abbott India and Redcliffe Labs Collaborate to Launch AI-Powered Clinical Reporting Solution 'AlinIQ' August 7, 2023 Through a partnership with Abbott India, a prominent global healthcare company, Redcliffe Labs has launched AlinIQ Clinical Decision Support (CDS), a groundbreaking solution that utilizes state-of-the-art technologies like Big Data Engines and Artificial Intelligence (AI).